BIND THERAPEUTICS INC Inactive Instrument
BIND Therapeutics Inc Share Price Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/01 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 24/16/24 |
| 1st Jan change | Capi. | |
|---|---|---|
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
